This 'Dynamo' Biotech Puts AI-Fueled Breakout In Motion

Relay Therapeutics (RLAY) shares have surged as much as 1,074% since bottoming in April 2025, and the Cambridge, Mass.-based biotech firm is now positioned for a fresh breakout, earning a blue dot in MarketSurge for stock market leadership. The company leverages AI and machine learning in its drug discovery platform.

Since bottoming out in April 2025, Relay Therapeutics RLAY shares have skyrocketed by as much as 1,074%. Now the biotech firm has a fresh breakout in its sights. With its 10-week moving average continuing its long ascent, the Cambridge, Mass.-based company earns a coveted blue dot in MarketSurge, a clear indication of stock market leadership. Biotech Taps AI And Machine… This 'Dynamo' Biotech Puts AI-Fueled Breakout In Motion Copyright ©2026 Investor's Business Daily, LLC. All rights reserved. 87990cbe856818d5eddac44c7b1cdeb8